loading

Finanzdaten der Compass Therapeutics Inc-Aktie (CMPX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
17.04%
12.77
15.39 11.93 13.34 9.711
Depreciation and Amortization
4.35%
0.154
0.161 0.164 0.18 0.194
Operating Income/Loss
17.04%
-12.77
-15.39 -11.93 -13.34 -9.711
Income/Loss From Continuing Operations Before Tax
19.59%
-10.79
-13.41 -9.964 -11.28 -7.837
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
19.59%
-10.79
-13.41 -9.964 -11.28 -7.837
Net Income/Loss
19.59%
-10.79
-13.41 -9.964 -11.28 -7.837
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
71,799%
136.61
0.19 127.42 126.73 126.38
Basic Earnings Per Share
20.00%
-0.08
-0.10 -0.08 -0.09 -0.06
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):